RUBY
Rubius Therapeutics, Inc
RUBY
RUBY
Delisted
RUBY was delisted on the 6th of March, 2023.
76 hedge funds and large institutions have $335M invested in Rubius Therapeutics, Inc in 2020 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 24 increasing their positions, 22 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
76
Holders Change
–
Holders Change %
0%
% of All Funds
1.68%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.07%
New
14
Increased
24
Reduced
22
Closed
13
Calls
$1K
Puts
–
Net Calls
+$1K
Net Calls Change
+$948K
Top Buyers
| 1 |
AG
Artal Group
Luxembourg
|
$17.3M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
$44.4M |
| 3 |
JPMorgan Chase & Co
New York
|
$5.22M |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
$2.67M |
| 5 |
Russell Investments Group
London,
United Kingdom
|
$656K |
